Antonio Rossi

1.6k total citations
29 papers, 442 citations indexed

About

Antonio Rossi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Antonio Rossi has authored 29 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 6 papers in Genetics. Recurrent topics in Antonio Rossi's work include Diabetes Management and Research (14 papers), Diabetes Treatment and Management (14 papers) and Pancreatic function and diabetes (9 papers). Antonio Rossi is often cited by papers focused on Diabetes Management and Research (14 papers), Diabetes Treatment and Management (14 papers) and Pancreatic function and diabetes (9 papers). Antonio Rossi collaborates with scholars based in Italy, United States and Australia. Antonio Rossi's co-authors include Laura Montefusco, Paolo Fiorina, Maria Elena Lunati, Ida Pastore, Gianvincenzo Zuccotti, Andrea Mario Bolla, Federica Ermetici, C Coman, Lelio Morricone and Massimiliano Marco Corsi Romanelli and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Antonio Rossi

27 papers receiving 437 citations

Peers

Antonio Rossi
Emilie H. Zobel Denmark
Vaneeta Bamba United States
Rita S. Patarrão Portugal
M. Traversa Italy
Havva Sezer Türkiye
Jennifer Taher Canada
Seong Bin Hong South Korea
Supamai Soonthornpun Thailand
Björn Wahlstrand Sweden
Katarzyna Musialik Poland
Emilie H. Zobel Denmark
Antonio Rossi
Citations per year, relative to Antonio Rossi Antonio Rossi (= 1×) peers Emilie H. Zobel

Countries citing papers authored by Antonio Rossi

Since Specialization
Citations

This map shows the geographic impact of Antonio Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Rossi more than expected).

Fields of papers citing papers by Antonio Rossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Rossi. The network helps show where Antonio Rossi may publish in the future.

Co-authorship network of co-authors of Antonio Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Rossi. A scholar is included among the top collaborators of Antonio Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Rossi. Antonio Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baccetti, Fabio, Davide Masi, Nicoletta Musacchio, et al.. (2025). Treatment Intensification Strategies and Metabolic Outcomes in Individuals With Type 2 Diabetes on GLP-1 RA Therapy. The Journal of Clinical Endocrinology & Metabolism. 110(12). e4101–e4110.
2.
Molfetta, Sergio Di, Antonio Rossi, Roberta Assaloni, et al.. (2025). Tips for successful use of commercial automated insulin delivery systems: An expert paper of the Italian working group on diabetes and technology. Diabetes Research and Clinical Practice. 223. 112117–112117. 2 indexed citations
3.
Masi, Davide, Fabio Baccetti, Besmir Nreu, et al.. (2024). Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control. SHILAP Revista de lepidopterología. 6(1). 420–434. 1 indexed citations
4.
Molfetta, Sergio Di, Antonio Rossi, Federico Boscari, et al.. (2024). Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert Opinion. Diabetes Therapy. 15(11). 2263–2278. 2 indexed citations
5.
Molfetta, Sergio Di, Antonio Rossi, Rosaria Gesuita, et al.. (2024). Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study. Acta Diabetologica. 62(4). 563–573. 4 indexed citations
6.
Musacchio, Nicoletta, Davide Masi, Fabio Baccetti, et al.. (2024). A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy. International Journal of Medical Informatics. 190. 105550–105550. 1 indexed citations
7.
Rossi, Antonio, Laura Montefusco, Ida Pastore, et al.. (2024). A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitus. Journal of Diabetes & Metabolic Disorders. 23(2). 2201–2205. 1 indexed citations
8.
Rossi, Antonio, Laura Montefusco, Ida Pastore, et al.. (2023). Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system. Diabetes Research and Clinical Practice. 206. 111011–111011. 1 indexed citations
9.
Cattaneo, Dario, Antonio Gidaro, Antonio Rossi, et al.. (2023). Management of diabetes mellitus in people living with HIV: A single-center experience. Frontiers in Pharmacology. 13. 3 indexed citations
10.
11.
12.
Pitocco, Dario, Andrea Laurenzi, L. Tomaselli, et al.. (2022). Health care organization and use of technological devices in people with diabetes in Italy: Results from a survey of the Working Group on Diabetes and Technology. Nutrition Metabolism and Cardiovascular Diseases. 32(10). 2392–2398. 9 indexed citations
13.
Rossi, Antonio, Laura Montefusco, Ida Pastore, et al.. (2022). One year of Hybrid Closed Loop on peritoneal dialysis: a case report. Acta Diabetologica. 59(7). 985–988. 5 indexed citations
14.
Lombardo, Patrizia, et al.. (2022). Integrated imaging of systemic Langerhans cell histiocytosis in an infant. SHILAP Revista de lepidopterología. 17(8). 2747–2753. 1 indexed citations
15.
Molfetta, Sergio Di, Antonio Rossi, Roberta Assaloni, et al.. (2022). A guide for the use of LibreView digital diabetes platform in clinical practice: Expert paper of the Italian Working Group on Diabetes and Technology. Diabetes Research and Clinical Practice. 187. 109867–109867. 7 indexed citations
16.
Gallieni, Maurizio, Maria Elena Lunati, Antonio Rossi, et al.. (2021). Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis. Acta Diabetologica. 58(8). 975–981. 14 indexed citations
17.
Berra, Cesare, Veronica Resi, Marco Mirani, et al.. (2020). Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes. Pharmacological Research. 159. 104996–104996. 19 indexed citations
18.
Montefusco, Laura, Sergio Harari, Davide Elia, et al.. (2017). Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis. European Journal of Internal Medicine. 51. 61–67. 18 indexed citations
19.
Rondinelli, Maurizio, Antonio Rossi, Loredana Bucciarelli, et al.. (2016). Use of Liraglutide in the Real World and Impact at 36 Months on Metabolic Control, Weight, Lipid Profile, Blood Pressure, Heart Rate, and Renal Function. Clinical Therapeutics. 39(1). 159–169. 18 indexed citations
20.
Sonaglioni, Andrea, Antonio Rossi, Laura Montefusco, et al.. (2016). Improved diastolic function in type 2 diabetes after a six month liraglutide treatment. Diabetes Research and Clinical Practice. 118. 21–28. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilie H. Zobel Breakdown of academic impact, for papers by Vaneeta Bamba Breakdown of academic impact, for papers by Rita S. Patarrão Breakdown of academic impact, for papers by M. Traversa Breakdown of academic impact, for papers by Havva Sezer Breakdown of academic impact, for papers by Jennifer Taher Breakdown of academic impact, for papers by Seong Bin Hong Breakdown of academic impact, for papers by Supamai Soonthornpun Breakdown of academic impact, for papers by Björn Wahlstrand Breakdown of academic impact, for papers by Katarzyna Musialik
Rankless by CCL
2026